REGENERON PHARMACEUTICALS, INC. (REGN)
SEC filings, insider trading & institutional ownership from EDGAR.
Institutions
46
$38.90B held
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G · latest quarter
| Holder | Filed | Value |
|---|---|---|
| BlackRock, Inc. | Aug 7, 2026 | $5.68B |
| Vanguard Capital Management | Aug 13, 2026 | $4.13B |
| Dodge & Cox | Aug 13, 2026 | $3.04B |
| STATE STREET CORP | Aug 7, 2026 | $3.01B |
| Invesco Ltd. | Aug 14, 2026 | $2.46B |
REGN's filings are public. The insight is one click away.
Scrutar's AI reads every REGN filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Red Flag Detection20+ forensic checks per filingRisk RadarYear-over-year changes in risk factorsFiling DNADisclosure quality scored across six dimensionsSupply Chain GraphCustomers, suppliers & competitors mapped
Analyze REGN filingsNo credit cardAI reports included on the free plan
Never miss a REGN filing.
Get an email when REGN files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Aug 29, 2026Source: SEC EDGAR.